Seasonal Malaria Chemoprevention in an Area of Extended Seasonal Transmission in Ashanti, Ghana: an Individually Randomised Clinical Trial

Overview

Journal Trop Med Int Health

Specialties Public Health
Tropical Medicine

Date 2015 Nov 19

PMID 26578353

Citations 30

Authors

Harry Tagbor

Gifty Dufie Antwi

Princess Ruhama Acheampong

Constance Bart Plange

Daniel Chandramohan

Matthew Cairns

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effectiveness of seasonal malaria chemoprevention (SMC) and community case management with long-acting artemisinin-based combination therapies (ACTs) for the control of malaria in areas of extended seasonal malaria transmission.

Method: Individually randomised, placebo-controlled trial in the Ashanti Region of Ghana. A total of 2400 children aged 3-59 months received either: (i) a short-acting ACT for case management of malaria (artemether-lumefantrine, AL) plus placebo SMC, or (ii) a long-acting ACT (dihydroartemisinin-piperaquine, DP) for case management plus placebo SMC or (iii) AL for case management plus active SMC with sulphadoxine-pyrimethamine and amodiaquine. SMC or placebo was delivered on five occasions during the rainy season. Malaria cases were managed by community health workers, who used rapid diagnostic tests to confirm infection prior to treatment.

Results: The incidence of malaria was lower in children given SMC during the rainy season. Compared to those given placebo SMC and AL for case management, the adjusted hazard ratio (aHR) was 0.62 (95% CI: 0.41, 0.93), P = 0.020 by intention to treat and 0.53 (95% CI: 0.29, 0.95), P = 0.033 among children given five SMC courses. There were no major differences between groups given different ACTs for case management (aHR DP vs. AL 1.18 (95% CI 0.83, 1.67), P = 0.356).

Conclusion: SMC may have an important public health impact in areas with a longer transmission season, but further optimisation of SMC schedules is needed to maximise its impact in such settings.

Citing Articles

Caregiver acceptability of seasonal malaria chemoprevention in two districts in the Upper West region, Ghana: a cross-sectional study.

Diarra Y, Opoku M, Amankwa C, Annor R, Nonvignon J, Bonful H Malar J. 2025; 24(1):14.

PMID: 39810150 PMC: 11734325. DOI: 10.1186/s12936-024-05169-6.

Population impact of malaria control interventions in the health district of Kati, Mali.

Katile A, Sagara I, Cissoko M, Bationo C, Dolo M, Dembele P PLoS One. 2024; 19(12):e0289451.

PMID: 39739743 PMC: 11687661. DOI: 10.1371/journal.pone.0289451.

Household-level effects of seasonal malaria chemoprevention in the Gambia.

Soremekun S, Conteh B, Nyassi A, Soumare H, Etoketim B, Ndiath M Commun Med (Lond). 2024; 4(1):97.

PMID: 38778226 PMC: 11111771. DOI: 10.1038/s43856-024-00503-0.

Prehospital use of point-of-care tests by community health workers: a scoping review.

Ebbs D, Taricia M, Funaro M, ODaniel M, Cappello M Front Public Health. 2024; 12:1360322.

PMID: 38721545 PMC: 11076783. DOI: 10.3389/fpubh.2024.1360322.

Malaria infection and predictor factors among Chadian nomads' children.

Moukenet A, Moudine K, Ngarasta N, Hinzoumbe C, Seck I BMC Public Health. 2024; 24(1):918.

PMID: 38549091 PMC: 10979592. DOI: 10.1186/s12889-024-18454-5.

References

Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson P . A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis. 2007; 45(1):16-25. DOI: 10.1086/518575. View

Cairns M, Walker P, Okell L, Griffin J, Garske T, Asante K . Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa. Malar J. 2015; 14:321. PMC: 4539702. DOI: 10.1186/s12936-015-0839-4. View

Ezeoke O, Ezumah N, Chandler C, Mangham-Jefferies L, Onwujekwe O, Wiseman V . Exploring health providers' and community perceptions and experiences with malaria tests in South-East Nigeria: a critical step towards appropriate treatment. Malar J. 2012; 11:368. PMC: 3507662. DOI: 10.1186/1475-2875-11-368. View

Coulibaly S, Kayentao K, Taylor S, Guirou E, Khairallah C, Guindo N . Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J. 2014; 13:41. PMC: 3914849. DOI: 10.1186/1475-2875-13-41. View

Zou G . A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159(7):702-6. DOI: 10.1093/aje/kwh090. View

Bojang K, Akor F, Conteh L, Webb E, Bittaye O, Conway D . Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med. 2011; 8(2):e1000409. PMC: 3032548. DOI: 10.1371/journal.pmed.1000409. View

Wilson A . A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One. 2011; 6(2):e16976. PMC: 3038871. DOI: 10.1371/journal.pone.0016976. View

Cheung Y, Xu Y, Tan S, Cutts F, Milligan P . Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined. Stat Med. 2009; 29(3):328-36. DOI: 10.1002/sim.3783. View

Cisse B, Sokhna C, Boulanger D, Milet J, Ba E, Richardson K . Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet. 2006; 367(9511):659-67. DOI: 10.1016/S0140-6736(06)68264-0. View

10.

Okell L, Cairns M, Griffin J, Ferguson N, Tarning J, Jagoe G . Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun. 2014; 5:5606. PMC: 4263185. DOI: 10.1038/ncomms6606. View

11.

. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011; 8(11):e1001119. PMC: 3210754. DOI: 10.1371/journal.pmed.1001119. View

12.

Cisse B, Cairns M, Faye E, Ndiaye O, Faye B, Cames C . Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One. 2009; 4(9):e7164. PMC: 2747010. DOI: 10.1371/journal.pone.0007164. View

13.

Flegg J, Patil A, Venkatesan M, Roper C, Naidoo I, Hay S . Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J. 2013; 12:249. PMC: 3728261. DOI: 10.1186/1475-2875-12-249. View

14.

Sokhna C, Cisse B, Ba E, Milligan P, Hallett R, Sutherland C . A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One. 2008; 3(1):e1471. PMC: 2198946. DOI: 10.1371/journal.pone.0001471. View

15.

Konate A, Yaro J, Ouedraogo A, Diarra A, Gansane A, Soulama I . Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011; 8(2):e1000408. PMC: 3032552. DOI: 10.1371/journal.pmed.1000408. View

16.

Druetz T, Fregonese F, Bado A, Millogo T, Kouanda S, Diabate S . Abolishing Fees at Health Centers in the Context of Community Case Management of Malaria: What Effects on Treatment-Seeking Practices for Febrile Children in Rural Burkina Faso?. PLoS One. 2015; 10(10):e0141306. PMC: 4621040. DOI: 10.1371/journal.pone.0141306. View

17.

Arinaitwe E, Sandison T, Wanzira H, Kakuru A, Homsy J, Kalamya J . Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis. 2009; 49(11):1629-37. DOI: 10.1086/647946. View

18.

Bigira V, Kapisi J, Clark T, Kinara S, Mwangwa F, Muhindo M . Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med. 2014; 11(8):e1001689. PMC: 4122345. DOI: 10.1371/journal.pmed.1001689. View

19.

Dicko A, Diallo A, Tembine I, Dicko Y, Dara N, Sidibe Y . Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011; 8(2):e1000407. PMC: 3032550. DOI: 10.1371/journal.pmed.1000407. View

20.

Cairns M, Roca-Feltrer A, Garske T, Wilson A, Diallo D, Milligan P . Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012; 3:881. PMC: 3621394. DOI: 10.1038/ncomms1879. View